Translational approaches have revolutionized the treatment options for psoriasis. New findings in the field of epidermal immunopathology form the basis for the optimization of highly effective substances. The new generation of system therapies leads to excellent results and convenience is also continuously improved. Much research is currently underway such as the concept of “resident memory T-cells” and the reduction of cardiovascular comorbidities as a side effect of treatment.